Nyxoah (NYXH) Share-based Compensation (2021 - 2026)
Nyxoah's (NYXH) quarterly Share-based Compensation came in at $18.0 million in Q1 2026, up 38.08% year-on-year from $13.0 million in Q1 2025, and up 1612.35% quarter-over-quarter from $1.1 million in Q4 2025.
Nyxoah (NYXH) Share-based Compensation (2021 - 2026) Analysis & Trends
Nyxoah's Share-based Compensation history runs 5 years deep, the most recent figure standing at $18.0 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 38.08% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was $9.6 million, a 41.26% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, up 34.13% from the prior year.
- Share-based Compensation improved to $18.0 million in Q1 2026 per NYXH's latest filing, from $1.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $18.0 million in Q1 2026 and bottomed at -$10.8 million in Q2 2025.
- The 4-year median for Share-based Compensation is $850983.5 (2022), against an average of $2.6 million.
- Across the five-year window, Share-based Compensation slumped 31.02% in 2025 and soared 38.08% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $573379.0 in 2022, then soared by 37.17% to $786486.2 in 2024, then soared by 33.65% to $1.1 million in 2025, then surged by 1612.35% to $18.0 million in 2026.
- Per Business Quant, the three latest NYXH Share-based Compensation figures stand at $18.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | 13.03 Mn |
| Mar 31, 2025 | 13.03 Mn |
| Dec 31, 2024 | 786,486.21 |
| Dec 31, 2024 | 786,486.21 |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Dec 31, 2022 | 573,379.02 |
| Dec 31, 2022 | 573,379.02 |
| Sep 30, 2022 | 850,983.53 |
| Sep 30, 2022 | 850,983.53 |
| Jun 30, 2022 | 669,044.54 |
| Jun 30, 2022 | 669,044.54 |